Your browser doesn't support javascript.
loading
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
Makishima, Hideki; Saiki, Ryunosuke; Nannya, Yasuhito; Korotev, Sophia; Gurnari, Carmelo; Takeda, June; Momozawa, Yukihide; Best, Steve; Krishnamurthy, Pramila; Yoshizato, Tetsuichi; Atsuta, Yoshiko; Shiozawa, Yusuke; Iijima-Yamashita, Yuka; Yoshida, Kenichi; Shiraishi, Yuichi; Nagata, Yasunobu; Kakiuchi, Nobuyuki; Onizuka, Makoto; Chiba, Kenichi; Tanaka, Hiroko; Kon, Ayana; Ochi, Yotaro; Nakagawa, Masahiro M; Okuda, Rurika; Mori, Takuto; Yoda, Akinori; Itonaga, Hidehiro; Miyazaki, Yasushi; Sanada, Masashi; Ishikawa, Takayuki; Chiba, Shigeru; Tsurumi, Hisashi; Kasahara, Senji; Müller-Tidow, Carsten; Takaori-Kondo, Akifumi; Ohyashiki, Kazuma; Kiguchi, Toru; Matsuda, Fumihiko; Jansen, Joop H; Polprasert, Chantana; Blombery, Piers; Kamatani, Yoichiro; Miyano, Satoru; Malcovati, Luca; Haferlach, Torsten; Kubo, Michiaki; Cazzola, Mario; Kulasekararaj, Austin G; Godley, Lucy A; Maciejewski, Jaroslaw P.
Afiliação
  • Makishima H; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Saiki R; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Nannya Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Korotev S; Departments of Medicine and Human Genetics, Section of Hematology/Oncology, The University of Chicago, Chicago, IL.
  • Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Takeda J; Department of Biomedicine and Prevention, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
  • Momozawa Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Best S; Laboratory for Genotyping Development, Center for Integrative Medical Sciences (IMS), RIKEN, Yokohama, Japan.
  • Krishnamurthy P; King's College Hospital NHS Foundation Trust, and King's College London, London, United Kingdom.
  • Yoshizato T; King's College Hospital NHS Foundation Trust, and King's College London, London, United Kingdom.
  • Atsuta Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Shiozawa Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.
  • Iijima-Yamashita Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Yoshida K; Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.
  • Shiraishi Y; Department of Advanced Diagnosis, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan.
  • Nagata Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Kakiuchi N; National Cancer Center Research Institute, Division of Genome Analysis Platform Development, Tokyo, Japan.
  • Onizuka M; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Chiba K; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Tanaka H; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Kon A; National Cancer Center Research Institute, Division of Genome Analysis Platform Development, Tokyo, Japan.
  • Ochi Y; Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Nakagawa MM; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Okuda R; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Mori T; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Yoda A; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Itonaga H; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Miyazaki Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Sanada M; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Ishikawa T; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Chiba S; Department of Advanced Diagnosis, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan.
  • Tsurumi H; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Kasahara S; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Müller-Tidow C; Department of Hematology, Gifu University, Gifu, Japan.
  • Takaori-Kondo A; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.
  • Ohyashiki K; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Kiguchi T; Department of Hematology, Kyoto University, Kyoto, Japan.
  • Matsuda F; Department of Hematology, Tokyo Medical University, Tokyo, Japan.
  • Jansen JH; Chugoku Central Hospital, Fukuyama, Japan.
  • Polprasert C; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Blombery P; Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Kamatani Y; Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Miyano S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Malcovati L; Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Haferlach T; National Cancer Center Research Institute, Division of Genome Analysis Platform Development, Tokyo, Japan.
  • Kubo M; Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Cazzola M; Medical and Dental, Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kulasekararaj AG; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Godley LA; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Maciejewski JP; Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Blood ; 141(5): 534-549, 2023 02 02.
Article em En | MEDLINE | ID: mdl-36322930
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / RNA Helicases DEAD-box / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies Limite: Adult / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / RNA Helicases DEAD-box / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies Limite: Adult / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article